TABLE 4.
Variable |
N370S Homozygotes(n=19) |
N370S Heterozygotes (n= 28) |
Pa | ||
---|---|---|---|---|---|
Median | Quantile (25–75%) |
Median | Quantile (25–75%) |
||
No. of women | 15(79%) | 12(43%) | 0.02b,c | ||
Age(y) | 50 | 37–55 | 46 | 33–51 | 0.33 |
Duration of enzyme replacement therapy (y) |
6 | 0–8 | 7 | 1–11 | 0.15 |
Liver volume (cm3) | 1,503 | 1,072–1,798 | 1,578 | 1,193–1,911 | 0.55 |
Spleen status score | 1 | 0–1 | 2 | 1–2 | <0.001c |
Bone marrow burden score | |||||
Lumbar spine | 3 | 0–4 | 5 | 3–7 | <0.01c |
Femur | 3 | 3–5 | 6 | 4–7 | <0.01c |
Total | 6 | 3–8 | 10 | 8–13 | <0.001c |
Wilcoxon's test.
Fisher's exact probability.
Statistically significant.